BeStock  

Agilent Technologies A

US equityMarket cap rank #437Diagnostics & ResearchGene Editing
$170.38 −$4.96 (-2.83%)
Market closed · Nov 20, 9:50 pm ET · Last extended-hours $170.00 -0.22%
Open$175.10
Prev close$175.34
Day range$169.40 – $175.13
Volume1.88M
Market cap$48.04B
P/E (TTM)33.6
Dividend yield0.59%

Fundamentals

Latest reported quarter: Q3, ended Jul 2026

Revenue$1.88B+8.1% YoY
Operating profit$444.00M+23.3% YoY
Net profit$362.00M+7.7% YoY
Diluted EPS$1.28+8.5% YoY
Free cash flow$439.00M+69.5% YoY
Operating cash flow$519.00M

Revenue, last 8 quarters

$1.7BOct '24$1.7BJan '25$1.7BApr '25$1.7BJul '25$1.9BOct '25$1.8BJan '26$1.8BApr '26$1.9BJul '26

Net profit, last 8 quarters

$351.0MOct '24$318.0MJan '25$215.0MApr '25$336.0MJul '25$434.0MOct '25$305.0MJan '26$339.0MApr '26$362.0MJul '26

Diluted EPS by quarter

1.22Oct '241.11Jan '250.75Apr '251.18Jul '251.53Oct '251.07Jan '261.20Apr '261.28Jul '26

Free cash flow by quarter

$388.0MOct '24$334.0MJan '25$107.0MApr '25$259.0MJul '25$452.0MOct '25$175.0MJan '26$201.0MApr '26$439.0MJul '26

Annual revenue

$5.3BFY20$6.3BFY21$6.8BFY22$6.8BFY23$6.5BFY24$6.9BFY25

Profitability & balance sheet

Gross margin53.8%
Operating margin22.2%
Net margin19.5%
Return on equity21.0%
Return on assets11.0%
Return on invested capital14.0%
Current ratio2.05
Liabilities / assets47.3%
Cash & investments$1.76B
Total debt$3.95B
Net cash (debt)-$2.19B
Free cash flow / sales17.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Agilent CrossLab$786.00M 41.9%
  • Life Sciences and Diagnostics Markets$746.00M 39.7%
  • Applied Markets$346.00M 18.4%

SEC annual financial snapshot

Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 16:51 UTC.

MetricUSDBasisPeriod endFiled / SEC source
Revenue$6.95BAnnual2025-10-312025-12-22
Net income$1.30BAnnual2025-10-312025-12-22
Operating cash flow$1.56BAnnual2025-10-312025-12-22
Total assets$12.73BPeriod end2025-10-312025-12-22
Total liabilities$5.99BPeriod end2025-10-312025-12-22
Stockholders’ equity$6.74BPeriod end2025-10-312025-12-22
Cash and cash equivalents$1.79BPeriod end2025-10-312025-12-22

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.88B $1.84B $1.80B $6.95B $1.86B
Total Operating Revenue $1.88B $1.84B $1.80B $6.95B $1.86B
Cost of Revenue $836.00M $845.00M $852.00M $3.31B $871.00M
Gross Profit $1.04B $990.00M $946.00M $3.64B $990.00M
Operating Expense $598.00M $591.00M $593.00M $2.16B $547.00M
Selling and Admin Expenses $475.00M $465.00M $476.00M $1.71B $428.00M
Research & Development $123.00M $126.00M $117.00M $455.00M $119.00M
Operating Profit $444.00M $399.00M $353.00M $1.48B $443.00M
Net Non-Operating Interest Income (Expense) -$14.00M -$12.00M -$10.00M -$50.00M -$10.00M
Non-Operating Interest Income $15.00M $13.00M $15.00M $62.00M $17.00M
Non-Operating Interest Expense $29.00M $25.00M $25.00M $112.00M $27.00M
Other Income (Expense) $14.00M $21.00M $21.00M $6.00M $9.00M
Other Non-Operating Income (Expenses) $14.00M $21.00M $21.00M $6.00M $9.00M
Pretax Profit $444.00M $408.00M $364.00M $1.44B $442.00M
Tax $82.00M $69.00M $59.00M $132.00M $8.00M
Net Profit $362.00M $339.00M $305.00M $1.30B $434.00M
Profit from Continuing Operations $362.00M $339.00M $305.00M $1.30B $434.00M
Net Income to Parent Company $362.00M $339.00M $305.00M $1.30B $434.00M
Net Income to Common Stockholders $362.00M $339.00M $305.00M $1.30B $434.00M
Basic EPS $1.28 $1.20 $1.08 $4.59 $1.53
Diluted EPS $1.28 $1.20 $1.07 $4.57 $1.53
Dividend Per Share $0.26 $0.26 $0.26 $0.99 $0.25

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $13.97B $13.07B $12.81B $12.73B $12.73B
Total Current Assets $4.69B $4.76B $4.62B $4.59B $4.59B
Cash and Cash Equivalents & Short-Term Investments $1.76B $1.81B $1.76B $1.79B $1.79B
-Cash and Cash Equivalents $1.76B $1.81B $1.76B $1.79B $1.79B
Receivables $1.48B $1.50B $1.52B $1.49B $1.49B
-Accounts Receivable $1.48B $1.50B $1.52B $1.49B $1.49B
Inventory $1.12B $1.09B $1.06B $1.03B $1.03B
Other Current Assets $340.00M $369.00M $277.00M $293.00M $293.00M
Total Non-Current Assets $9.27B $8.30B $8.20B $8.13B $8.13B
Net PPE $2.13B $2.10B $2.08B $2.02B $2.02B
Investments and Advances $130.00M $136.00M $135.00M $133.00M $133.00M
Goodwill and Other Intangible Assets $5.94B $4.89B $4.91B $4.92B $4.92B
-Goodwill $5.03B $4.48B $4.48B $4.47B $4.47B
-Other Intangible Assets $906.00M $407.00M $426.00M $445.00M $445.00M
Other Non-Current Assets $1.07B $1.18B $1.08B $1.06B $1.06B
Total Liabilities $6.60B $5.94B $5.91B $5.99B $5.99B
Total Current Liabilities $2.29B $2.27B $2.23B $2.35B $2.35B
Payables $608.00M $615.00M $602.00M $570.00M $570.00M
-Accounts Payable $608.00M $615.00M $602.00M $570.00M $570.00M
Current Accrued Expenses $314.00M $298.00M $349.00M $406.00M $406.00M
Short-Term Debt and Capital Lease Obligation $304.00M $304.00M $304.00M $304.00M $304.00M
-Current Debt $304.00M $304.00M $304.00M $304.00M $304.00M
Current Deferred Liabilities $640.00M $665.00M $682.00M $624.00M $624.00M
Total Non-Current Liabilities $4.32B $3.67B $3.67B $3.64B $3.64B
Long Term Debt and Capital Lease Obligation $3.65B $3.05B $3.05B $3.05B $3.05B
-Long Term Debt $3.65B $3.05B $3.05B $3.05B $3.05B
Employee Benefits $128.00M $127.00M $130.00M $126.00M $126.00M
Other Non-Current Liabilities $542.00M $496.00M $491.00M $463.00M $463.00M
Total Equity $7.36B $7.12B $6.91B $6.74B $6.74B
Stockholders' Equity $7.36B $7.12B $6.91B $6.74B $6.74B
Capital Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Common Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $5.68B $5.63B $5.61B $5.58B $5.58B
Retained Earnings $1.91B $1.69B $1.48B $1.39B $1.39B
Gains/Losses Not Affecting Retained Earnings -$233.00M -$202.00M -$184.00M -$226.00M -$226.00M
-Gross PPE – – – $3.45B $3.45B
-Accumulated Depreciation – – – -$1.42B -$1.42B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $519.00M $277.00M $268.00M $1.56B $545.00M
Net cash flow from continuing operations $519.00M $277.00M $268.00M $1.56B $545.00M
Net Income from Continuing Operations $362.00M $339.00M $305.00M $1.30B $434.00M
Gain/Loss from Continuing Operations $3.00M $1.00M -$2.00M $36.00M $8.00M
Depreciation & Depletion & Amortization $66.00M $67.00M $67.00M $288.00M $71.00M
Deferred Tax $20.00M $32.00M $25.00M -$130.00M -$95.00M
Other Non-Cash Items $18.00M $17.00M $12.00M $50.00M $16.00M
Change in Working Capital $18.00M -$211.00M -$180.00M -$131.00M $85.00M
-Change in Receivables $22.00M $12.00M -$18.00M -$149.00M -$105.00M
-Change in Inventory -$25.00M -$46.00M -$39.00M -$97.00M -$25.00M
-Change in Payables and Accrued Expense -$13.00M $15.00M $39.00M $16.00M $29.00M
-Change In Other Working Capital $34.00M -$192.00M -$162.00M $99.00M $186.00M
Net cash flow from investing -$1.03B -$77.00M -$93.00M -$394.00M -$90.00M
Net Cash Flow from Continuing Investing Activities -$1.03B -$77.00M -$93.00M -$394.00M -$90.00M
Net PPE Purchase and Sale -$80.00M -$76.00M -$93.00M -$407.00M -$93.00M
Net Business Purchase and Sale -$950.00M $0.00 $0.00 $4.00M $0.00
Net Other Investing Changes -$2.00M – – $1.00M $0.00
Financing Cash Flow $471.00M -$144.00M -$222.00M -$715.00M -$200.00M
Net Cash Flow from Continuing Financing Activities $471.00M -$144.00M -$222.00M -$715.00M -$200.00M
Net Issuance Payments Of Debt $597.00M -$3.00M -$2.00M -$41.00M -$56.00M
Net Common Stock Issuance -$78.00M -$65.00M -$152.00M -$425.00M -$85.00M
Cash Dividends Paid -$72.00M -$72.00M -$72.00M -$282.00M -$70.00M
Proceeds from Stock Option Exercised $31.00M $1.00M $31.00M $72.00M $12.00M
Net Other Financing Charges -$7.00M -$5.00M -$27.00M -$39.00M -$1.00M
Ending Cash Balance $1.76B $1.81B $1.76B $1.79B $1.79B
Net Change in Cash -$42.00M $56.00M -$47.00M $450.00M $255.00M
Beginning Cash Balance $1.81B $1.76B $1.79B $1.33B $1.54B
Effect of Exchange Rate Changes -$7.00M -$7.00M $16.00M $9.00M -$1.00M
Free Cash Flow $439.00M $201.00M $175.00M $1.15B $452.00M
Net Investment Purchase and Sale – – – $8.00M $3.00M

Discussion

No comments yet — be the first to weigh in on A.

Sign in to join the discussion.

Scroll to Top